| Name | Title | Contact Details |
|---|
Vext Science is an established U.S. cannabis operator, based in Arizona. Follow for investor relations and corporate updates (OTCQX: VEXTF; CSE: VEXT)
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Trifecta Clinical is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aaron Diamond AIDS Research Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cofounded by Frank M. Reynolds, MIT`s Dr. Robert S. Langer, Katrin Holzhaus, and Dr. Jason Criscione, PixarBio researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson`s disease, and spinal cord injury.